The structural basis of ZMPSTE24-dependent laminopathies.

The structural basis of ZMPSTE24-dependent laminopathies.

Εμφάνιση άλλων εκδόσεων (1)

Mutations in the nuclear membrane zinc metalloprotease ZMPSTE24 lead to diseases of lamin processing (laminopathies), such as the premature aging disease progeria and metabolic disorders. ZMPSTE24 processes prelamin A, a component of the nuclear lamina intermediate filaments, by cleaving it at two s...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Quigley, A, Dong, Y, Pike, A, Dong, L, Shrestha, L, Berridge, G, Stansfeld, P, Sansom, MS, Edwards, A, Bountra, C, von Delft, F, Bullock, A, Burgess-Brown, N, Carpenter, E
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

The structural basis of ZMPSTE24-dependent laminopathies
ανά: Quigley, A, κ.ά.
Έκδοση: (2013)

Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24
ανά: Mehmood, S, κ.ά.
Έκδοση: (2016)

Prelamin A and ZMPSTE24 in premature and physiological aging
ανά: Howard J. Worman, κ.ά.
Έκδοση: (2023-12-01)

ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
ανά: Moritz Messner, κ.ά.
Έκδοση: (2020-08-01)

Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
ανά: Jemima Barrowman, κ.ά.
Έκδοση: (2012-01-01)

Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound states.
ανά: Shintre, C, κ.ά.
Έκδοση: (2013)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
ανά: Spear, ED, κ.ά.
Έκδοση: (2018)

ZMPSTE24 missense mutations that cause progeroid diseases decrease prelamin A cleavage activity and/or protein stability
ανά: Eric D. Spear, κ.ά.
Έκδοση: (2018-07-01)

Deciphering Nuclear Mechanobiology in Laminopathy
ανά: Jungwon Hah, κ.ά.
Έκδοση: (2019-03-01)

运用二代测序技术产前诊断ZMPSTE24基因突变
ανά: 麦明琴, κ.ά.
Έκδοση: (2017-01-01)

The Senolytic Drug Fisetin Attenuates Bone Degeneration in the Zmpste24−/− Progeria Mouse Model
ανά: William S. Hambright, κ.ά.
Έκδοση: (2023-01-01)

Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24-deficient mice
ανά: Jie Zhang, κ.ά.
Έκδοση: (2024-05-01)

Inhibition of Arenavirus Entry and Replication by the Cell-Intrinsic Restriction Factor ZMPSTE24 Is Enhanced by IFITM Antiviral Activity
ανά: Robert J. Stott-Marshall, κ.ά.
Έκδοση: (2022-02-01)

Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24.
ανά: Kaitlin M Wood, κ.ά.
Έκδοση: (2020-01-01)

Clinical and genetic characteristics of hereditary laminopathies
ανά: E. L. Dadaly, κ.ά.
Έκδοση: (2017-02-01)

Clinical and diagnostic difficulties in management of patients with laminopathies
ανά: O. V. Melnik, κ.ά.
Έκδοση: (2019-11-01)

From loss to gain: role for SUN1 in laminopathies
ανά: Liu Baohua, κ.ά.
Έκδοση: (2012-06-01)

Accelerated aging in articular cartilage by ZMPSTE24 deficiency leads to osteoarthritis with impaired metabolic signaling and epigenetic regulation
ανά: Jinlong Suo, κ.ά.
Έκδοση: (2023-05-01)

A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy
ανά: Damien Galant, κ.ά.
Έκδοση: (2016-04-01)

Deficiency in ZMPSTE24 and resulting farnesyl–prelamin A accumulation only modestly affect mouse adipose tissue stores[S]
ανά: Patrick J. Heizer, κ.ά.
Έκδοση: (2020-03-01)

Cellular and Animal Models of Striated Muscle Laminopathies
ανά: Hannah A. Nicolas, κ.ά.
Έκδοση: (2019-03-01)

AN ORPHAN PHENOTYPE OF CARDIOGENITAL LAMINOPATHY — MALOUF SYNDROME
ανά: T. G. Vaykhanskaya, κ.ά.
Έκδοση: (2016-11-01)

Restrictive Dermopathy Due to ZMPSTE24 Mutation: A Case Report with a Novel Finding of Corpus Callosum Agenesis
ανά: Minu Jose Chiramel, κ.ά.
Έκδοση: (2024-01-01)

Lamin A/C Mechanotransduction in Laminopathies
ανά: Francesca Donnaloja, κ.ά.
Έκδοση: (2020-05-01)

Nuclear damages and oxidative stress: new perspectives for laminopathies
ανά: G. Lattanzi, κ.ά.
Έκδοση: (2012-10-01)

Structural basis for ASPP2 recognition by the tumor suppressor p73
ανά: Canning, P, κ.ά.
Έκδοση: (2012)

Structural basis for ASPP2 recognition by the tumor suppressor p73.
ανά: Canning, P, κ.ά.
Έκδοση: (2012)

Cardiac involvement in laminopathies – short invited review
ανά: Gerardo Nigro, κ.ά.
Έκδοση: (2015-12-01)

Implications and Assessment of the Elastic Behavior of Lamins in Laminopathies
ανά: Subarna Dutta, κ.ά.
Έκδοση: (2016-10-01)

Inflammatory myopathy in the context of an unusual overlapping laminopathy
ανά: Cristina Guillín-Amarelle, κ.ά.
Έκδοση: (2018-05-01)

The empowerment of translational research: lessons from laminopathies
ανά: Benedetti Sara, κ.ά.
Έκδοση: (2012-06-01)

HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
ανά: Goulbourne, C, κ.ά.
Έκδοση: (2010)

Simulations of the BM2 proton channel transmembrane domain from influenza virus B.
ανά: Rouse, S, κ.ά.
Έκδοση: (2009)

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B
ανά: Kamsi O. Odinammadu, κ.ά.
Έκδοση: (2023-12-01)

The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation
ανά: Khurts Shilagardi, κ.ά.
Έκδοση: (2022-10-01)

Embryonic Senescence and Laminopathies in a Progeroid Zebrafish Model
ανά: Koshimizu, Eriko, κ.ά.
Έκδοση: (2011)

Embryonic senescence and laminopathies in a progeroid zebrafish model.
ανά: Eriko Koshimizu, κ.ά.
Έκδοση: (2011-03-01)

Risk stratification in laminopathies and Emery Dreifuss muscular dystrophy
ανά: Abdallah Fayssoil
Έκδοση: (2018-04-01)

Emery-Dreifuss muscular dystrophy: the most recognizable laminopathy
ανά: Agnieszka Madej-Pilarczyk, κ.ά.
Έκδοση: (2016-03-01)

Aberrant chromatin organization at the nexus of laminopathy disease pathways
ανά: Garrett T. Santini, κ.ά.
Έκδοση: (2022-12-01)